Kyleena 19.5 MG systems
Ended Awarded
- Contract number
- SPE2DB26FQAAT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,239
Award facts
- Contract value 100% obligated
- $1,239.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $1,239.40 to DMS Pharmaceutical Group Inc. for Kyleena 19.5 mg contraceptive systems, awarded on November 6, 2025, with an ultimate completion date of December 1, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery will be performed in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency designated as SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract, awarded November 13, 2025, carries a $499.999 billion ceiling value through December 31, 2036, and positions DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities worldwide. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy, authorizing DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support recurring medical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FQAAT?
SPE2DB26FQAAT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FQAAT worth?
The government has obligated $1,239 on SPE2DB26FQAAT.
Is contract SPE2DB26FQAAT an order under another contract?
Yes. SPE2DB26FQAAT is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB26FQAAT competed?
The extent of competition for SPE2DB26FQAAT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award